Quarterly report · Q1
4572.TEDINET S100TC6I
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥181m | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥1.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥227m | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | −¥416m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥506m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥394m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.1bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥513m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥397m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥514m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥399m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥519m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥399m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥519m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥3.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥4.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥4.9bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥376m | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥472m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-23.27 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-68.62 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.78 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.1% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥418m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥181m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥181m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q1r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥570m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥64m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 296
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating expenses | Prior1YTDDuration | 7769000 | JPY |
| Non operating expenses | CurrentYTDDuration | 1025000 | JPY |
| Ordinary income | Prior1YTDDuration | -513368000 | JPY |
| Ordinary income | CurrentYTDDuration | -394494000 | JPY |
| Impairment loss el | Prior1YTDDuration | 462000 | JPY |
| Impairment loss el | CurrentYTDDuration | 2612000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 462000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 2612000 | JPY |
| Income before income taxes | Prior1YTDDuration | -513831000 | JPY |
| Income before income taxes | CurrentYTDDuration | -397106000 | JPY |
| Income taxes current | Prior1YTDDuration | 5407000 | JPY |
| Income taxes current | CurrentYTDDuration | 1810000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -28000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -26000 | JPY |
| Income taxes | Prior1YTDDuration | 5378000 | JPY |
| Income taxes | CurrentYTDDuration | 1783000 | JPY |
| Profit loss | Prior1YTDDuration | -519210000 | JPY |
| Profit loss | CurrentYTDDuration | -398890000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -519210000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -398890000 | JPY |
| Profit loss | Prior1YTDDuration | -519210000 | JPY |
| Profit loss | CurrentYTDDuration | -398890000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -101000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -229000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | -615000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 19240000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 1648000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 20316000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 932000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 39327000 | JPY |
| Comprehensive income | Prior1YTDDuration | -518278000 | JPY |
| Comprehensive income | CurrentYTDDuration | -359563000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -518278000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -359563000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoverySupportBusinessReportableSegmentsMember | 226967000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoveryBusinessReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 226967000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoverySupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoveryBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoverySupportBusinessReportableSegmentsMember | 226967000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoveryBusinessReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration | 226967000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoverySupportBusinessReportableSegmentsMember | 64343000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoveryBusinessReportableSegmentsMember | -570136000 | JPY |
| Operating income | Prior1YTDDuration | -505792000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoverySupportBusinessReportableSegmentsMember | 180870000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00987-000DrugDiscoveryBusinessReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |